Varon J, Marik P E
Department of Medicine, Baylor College of Medicine, Houston TX, USA.
Chest. 2000 Jul;118(1):214-27. doi: 10.1378/chest.118.1.214.
Severe hypertension is a common clinical problem in the United States, encountered in various clinical settings. Although various terms have been applied to severe hypertension, such as hypertensive crises, emergencies, or urgencies, they are all characterized by acute elevations in BP that may be associated with end-organ damage (hypertensive crisis). The immediate reduction of BP is only required in patients with acute end-organ damage. Hypertension associated with cerebral infarction or intracerebral hemorrhage only rarely requires treatment. While nitroprusside is commonly used to treat severe hypertension, it is an extremely toxic drug that should only be used in rare circumstances. Furthermore, the short-acting calcium channel blocker nifedipine is associated with significant morbidity and should be avoided. Today, a wide range of pharmacologic alternatives are available to the practitioner to control severe hypertension. This article reviews some of the current concepts and common misconceptions in the management of patients with acutely elevated BP.
重度高血压在美国是一个常见的临床问题,在各种临床环境中都会遇到。尽管针对重度高血压应用了各种术语,如高血压危象、急症或紧急情况,但它们的共同特征都是血压急性升高,可能伴有靶器官损害(高血压危象)。仅在有急性靶器官损害的患者中需要立即降低血压。与脑梗死或脑出血相关的高血压很少需要治疗。虽然硝普钠常用于治疗重度高血压,但它是一种剧毒药物,仅应在罕见情况下使用。此外,短效钙通道阻滞剂硝苯地平会导致显著的发病率,应避免使用。如今,从业者有多种药物可供选择来控制重度高血压。本文回顾了急性血压升高患者管理中的一些当前概念和常见误解。